Oct 3, 2022
On this episode, we review the data that lead to some SGLT-2 inhibitors being used routinely in heart failure. We discuss the initial cardiovascular safety studies that initially showed heart failure benefit in this class. Then we look as some of the newer studies that have looked at empagliflozin and dapagliflozin...
Sep 27, 2022
On this episode, we discuss deucravacitinib tablets (Sotyktu), roflumilast cream (Zoryve), and tapinarof cream (Vtama). All three medications were approved in 2022 and represent new classes of medication for the treatment of plaque psoriasis. We also give a brief overview of the older treatment options that are used...
Sep 20, 2022
On this episode, we review the pharmacology/pharmacotherapy of anticoagulants. We compare and contrast the various agents currently available, and briefly discuss their roles in various disease states (VTE, Afib, etc).
Cole and I are happy to share that our listeners can claim ACPE-accredited continuing education for...
Sep 12, 2022
On this episode, AJ and I discuss the OTC cognitive support supplement called Prevagen. We review the data that supposedly justifies this product being the top seller in this supplement space. These are just our opinions based on the available data. If you disagree, we would love to hear why.
Thanks for listening!
We...
Sep 12, 2022
On this episode, we cover various menstruation-related
disorders. We review amenorrhea, heavy menstrual bleeding, PCOS,
dysmenorrhea, PMS, and PMDD.
Cole and I are happy to share that our listeners can claim ACPE-accredited continuing education for listening to this podcast episode! We have continued to partner with...